What Lexiscan Does During a Myocardial Perfusion Study
Lexiscan (regadenoson) causes coronary vasodilation by selectively stimulating A2A adenosine receptors, which increases blood flow in normal coronary arteries more than in stenotic ones, creating regional perfusion differences that can be visualized with nuclear imaging to detect myocardial ischemia. 1
Mechanism of Action
Regadenoson works as a selective A2A adenosine receptor agonist that produces coronary vasodilation 2. Unlike exercise or dobutamine that increase myocardial oxygen demand, regadenoson reduces myocardial oxygen supply through a "steal phenomenon" 2:
- Normal coronary arteries dilate maximally and receive increased blood flow
- Stenotic arteries cannot dilate adequately due to pre-existing maximal vasodilation at rest
- This creates regional perfusion differences that appear as defects on nuclear imaging 3
The mechanism involves both horizontal steal (through collateral circulation) and vertical steal (with critical stenosis) 2.
Key Advantages Over Other Vasodilators
Regadenoson's selective A2A receptor activity avoids or reduces undesirable effects from A1, A2B, and A3 receptor stimulation, specifically minimizing dyspnea, bronchospasm, headache, and flushing 2. This makes it particularly valuable in patients with:
- Mild-to-moderate reactive airway disease or COPD - where adenosine would be contraindicated 4, 5
- Bronchospasm concerns - regadenoson has a more favorable side-effect profile 4
Administration Protocol
The drug is given as a fixed 0.4 mg bolus in 5 mL solution injected over 10 seconds, followed immediately by a 5 mL saline flush 2, 1. The radionuclide tracer is then injected 10-20 seconds after the saline flush 1.
Critical timing: Optimal image acquisition occurs 2-4 minutes after drug infusion when peak vasodilatory effect is achieved 2.
Clinical Context
Lexiscan is FDA-approved specifically as a pharmacologic stress agent for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress 1. This includes patients with:
- Deconditioning
- Peripheral vascular disease
- Orthopedic disabilities
- Neurological disease
- Other conditions preventing adequate exercise 3
Important Caveats
Contraindications include second- or third-degree AV block and sinus node dysfunction without a functioning pacemaker 1. The drug can cause transient hemodynamic changes including increased heart rate and decreased blood pressure 6, 7.
Residual hyperemia: Recent evidence shows that even after aminophylline reversal, myocardial blood flow does not completely return to baseline resting values 8. Therefore, a rest/stress protocol is essential - recovery images cannot substitute for true resting images when calculating myocardial perfusion reserve.
The workflow is simplified compared to adenosine (which requires an infusion pump and weight-based dosing) since regadenoson uses a fixed bolus dose administered by hand-held syringe 2, though it is more expensive than other vasodilators 2.